Legal & General Group
INBX

Legal & General Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Legal & General Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,765
Closed -$726K – 3587
2024
Q1 		$726K Buy
20,765
+1,500
+8% +$54.7K ﹤0.01% 2297
2023
Q4 		$732K Sell
19,265
-2,896
-13% -$62.1K ﹤0.01% 2318
2023
Q3 		$407K Sell
22,161
-262
-1% -$5.48K ﹤0.01% 2515
2023
Q2 		$582K Buy
22,423
+10,546
+89% +$246K ﹤0.01% 2415
2023
Q1 		$224K Buy
11,877
+2,002
+20% +$46.6K ﹤0.01% 2552
2022
Q4 		$243K Buy
9,875
+253
+3% +$7.44K ﹤0.01% 2534
2022
Q3 		$173K Buy
9,622
+1,239
+15% +$22.3K ﹤0.01% 2676
2022
Q2 		$95K Buy
8,383
+2,892
+53% +$42.5K ﹤0.01% 2871
2022
Q1 		$122K Sell
5,491
-9
-0.2% -$230 ﹤0.01% 2820
2021
Q4 		$241K Buy
5,500
+48
+0.9% +$1.92K ﹤0.01% 2646
2021
Q3 		$182K Buy
5,452
+1,824
+50% +$55.5K ﹤0.01% 2722
2021
Q2 		$100K Buy
3,628
+2,094
+137% +$43.6K ﹤0.01% 2735
2021
Q1 		$31K Buy
1,534
+676
+79% +$19.7K ﹤0.01% 2986
2020
Q4 		$28K Buy
+858
New +$22.8K ﹤0.01% 2974

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Legal & General Group's INBX Position: Q2 2024 in Review

Legal & General Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 20,765 shares — an estimated $726K sold.

Legal & General Group first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $732K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Legal & General Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 20,765 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $726K.
  • Legal & General Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Legal & General Group's Inhibrx, Inc. Common Stock position peaked at $732K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.